Bio-Works Technologies AB (BIOWKS) — Cash Flow Reinvestment Rate
Latest as of June 2021:
0.10x
Bio-Works Technologies AB (BIOWKS) has a Cash Flow Reinvestment Rate of 0.10x as of June 2021, reinvesting Skr891.00K (capex Skr891.00K ) from operating cash flow of Skr9.35 Million. Check BIOWKS operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.10x
(Capex + Investments) / Operating CF
Total Reinvested
Skr891.00K
Capex + Investments
Operating Cash Flow
Skr9.35 Million
SEK
Capital Expenditures
Skr891.00K
SEK
Annual Cash Flow Reinvestment Rate for Bio-Works Technologies AB (None–None)
Year-by-year capital reinvestment analysis for Bio-Works Technologies AB. For live market cap and broader valuation context, see BIOWKS market cap overview.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow